© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
January 19, 2022
Targeting skin care regimens to the individual patient is most likely to yield compliance to a recommended routine.
Studies offer positive outcomes for patients with conditions like hidradenitis suppurativa or psoriasis.
January 18, 2022
As skin manifestations are commonly the first thing spotted with infectious disease, dermatologists are in a great position to counsel patients about prevention.
January 17, 2022
AbbVie announced the approval after 3 studies show the efficacy and safety of upadacitinib using mono- and combination therapy.
January 12, 2022
A national survey found that patients are willing to try medical cannabis products as potential treatments of their condition. Additionally, some already use over-the-counter cannabis products.
June 02, 2021
The FDA approved Cosentyx (secukinumab) to treat moderate-to-severe plaque psoriasis in children aged 6 years and older.
May 27, 2021
A recent test found various brands and batches of sunscreen and after-sun care products contained benzene, a potential carcinogen.
April 26, 2021
Tremfya phase 3 data shows skin clearance rates were maintained at 5 years with 55.5% of patients achieving an IGA score of 0% and 53% achieving PASI 100 response in VOYAGE 2 trial.
December 15, 2020
Tirbanibulin (Klisyri; Almirall) is indicated for the topical treatment of actinic keratosis on the face or scalp.
October 16, 2020
Clascoterone cream 1% is a first-in-class topical acne treatment that targets the androgen receptors in the skin.